INQ000485977 - Witness Statement provided by Ben Osborn (President, International Commercial Office for Pfizer) on behalf of Pfizer Limited, dated 03/12/2024.

You are using a web browser with JavaScript disabled. Some of the features of this website may not function as intended.

Witness Statement provided by Ben Osborn (President, International Commercial Office for Pfizer) on behalf of Pfizer Limited, dated 03/12/2024.

Download this document